Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples